Diatrizoate
- Generic Name
- Diatrizoate
- Brand Names
- Cystografin, Cystografin Dilute, Gastrografin, Hypaque, Md-Gastroview
- Drug Type
- Small Molecule
- Chemical Formula
- C11H9I3N2O4
- CAS Number
- 117-96-4
- Unique Ingredient Identifier
- 5UVC90J1LK
- Background
A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
- Indication
Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
- Associated Conditions
- -
- Associated Therapies
- -
Optimizing Treatment of Adhesive Small Bowel Obstruction
- Conditions
- Interventions
- First Posted Date
- 2023-12-26
- Last Posted Date
- 2024-05-08
- Lead Sponsor
- University of California, Los Angeles
- Target Recruit Count
- 40
- Registration Number
- NCT06182319
- Locations
- 🇺🇸
University of California, Los Angeles, David Geffen School of Medicine, Los Angeles, California, United States
Bowel Preparation Regimen for Colon Capsule Endoscopy Procedure
- First Posted Date
- 2023-02-13
- Last Posted Date
- 2024-02-28
- Lead Sponsor
- Region Skane
- Target Recruit Count
- 147
- Registration Number
- NCT05726097
- Locations
- 🇸🇪
Skåne University Hospital, Malmö, Sweden
The Use of Gastrografin in Chronic Radiation Enteropathy With Small Bowel Obstruction
- First Posted Date
- 2018-08-22
- Last Posted Date
- 2018-08-22
- Lead Sponsor
- Jinling Hospital, China
- Target Recruit Count
- 112
- Registration Number
- NCT03642288
The Use of Gastrografin to Help Alleviate Bowel Obstruction in Gastroschisis Patients.
- First Posted Date
- 2017-11-07
- Last Posted Date
- 2023-11-01
- Lead Sponsor
- Lawson Health Research Institute
- Registration Number
- NCT03334578
- Locations
- 🇨🇦
Children's Hospital, London Health Sciences Centre, London, Ontario, Canada
Clinical and Financial Impact of an Evidenced-Based Adhesive Small Bowel Obstruction Management Protocol
- Conditions
- Interventions
- First Posted Date
- 2016-10-10
- Last Posted Date
- 2018-12-04
- Lead Sponsor
- The Guthrie Clinic
- Registration Number
- NCT02928458
- Locations
- 🇺🇸
The Guthrie Clinic, Sayre, Pennsylvania, United States
Uniformity of Oral Contrast Material in the Bowel
- Conditions
- Interventions
- First Posted Date
- 2015-09-04
- Last Posted Date
- 2019-12-11
- Lead Sponsor
- University of California, San Francisco
- Target Recruit Count
- 900
- Registration Number
- NCT02542046
- Locations
- 🇺🇸
UCSF, San Francisco, California, United States
Gastrografin in Postoperative Ileus
- First Posted Date
- 2012-07-25
- Last Posted Date
- 2014-07-04
- Lead Sponsor
- University of Auckland, New Zealand
- Registration Number
- NCT01648972
- Locations
- 🇳🇿
Auckland City Hospital, Auckland, AKL, New Zealand
Impact of Oral Application of Gastrografin on the Meconium Evacuation in Very Low Birth Weight Infants
- Conditions
- Interventions
- First Posted Date
- 2012-01-24
- Last Posted Date
- 2014-07-18
- Lead Sponsor
- Nadja Haiden,MD
- Target Recruit Count
- 96
- Registration Number
- NCT01515696
Study of the Effect of Water Soluble Oral Contrast (Gastrografin) on Postoperative Ileus After Colorectal Surgery
- Conditions
- Interventions
- First Posted Date
- 2011-09-26
- Last Posted Date
- 2014-07-15
- Lead Sponsor
- Hospital Universitari de Bellvitge
- Target Recruit Count
- 58
- Registration Number
- NCT01440712
- Locations
- 🇪🇸
Hospital Universitari de Girona, Girona, Spain
🇪🇸Hospital Universitari de la Vall d´Hebron, Barcelona, Spain
🇪🇸Hospital Universitari Bellvitge, L´Hospitalet de Llobregat, Barcelona, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.